A Study of XZP-3621 in Chinese Patients With ALK Positive NSCLC

NCT05482087 · clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
190
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Xuanzhu Biopharmaceutical Co., Ltd.